Lisata Therapeutics (LSTA) Change in Acquisitions & Divestments (2017 - 2025)
Lisata Therapeutics filings provide 9 years of Change in Acquisitions & Divestments readings, the most recent being $5.1 million for Q3 2025.
- For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 43.8% year-over-year to $5.1 million, compared with a TTM value of $24.3 million through Dec 2025, down 64.82%, and an annual FY2025 reading of $24.3 million, down 64.82% over the prior year.
- Change in Acquisitions & Divestments hit $5.1 million in Q3 2025 for Lisata Therapeutics, up from $4.6 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $34.4 million in Q1 2023, with the low at $4.6 million in Q2 2025.
- Median Change in Acquisitions & Divestments over the past 3 years was $15.4 million (2023), compared with a mean of $18.4 million.
- The sharpest move saw Change in Acquisitions & Divestments decreased 14.83% in 2024, then tumbled 78.37% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $15.4 million in 2023, then dropped by 14.83% to $13.1 million in 2024, then plummeted by 60.76% to $5.1 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $5.1 million, $4.6 million, and $14.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.